| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/28/2001 | CN1063664C Chinese medicine for treating gastrosis |
| 03/28/2001 | CN1063663C Medicine for treating colonitis and preparation method |
| 03/28/2001 | CN1063662C Preparation method of medicine-Qingquitesu and Products thereof |
| 03/28/2001 | CN1063661C Traditional chinese medicine for treating gastric disease and preparation process thereof |
| 03/28/2001 | CN1063660C Chinese medicine preparation for curing residual jaundice of viral hepatitis |
| 03/28/2001 | CN1063659C Chinese plaster for curing liver diseases and its preparation method |
| 03/28/2001 | CN1063655C Pure traditional Chinese medicine concentrated capsule for treating hepatitis B |
| 03/28/2001 | CN1063634C Medicine for treating cirrhosis and preparation method |
| 03/27/2001 | US6207852 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 03/27/2001 | US6207836 Indolin-2-one derivatives |
| 03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207687 Substituted imidazoles having cytokine inhibitory activity |
| 03/27/2001 | US6207686 Endothelin antagonists |
| 03/27/2001 | US6207683 Benzocycloheptathiophene compounds |
| 03/27/2001 | US6207678 Used for treating inflammatory disease such as arthritis, psoriasis, asthma or inflammatory bowel disease, central nervous system disorder such as anxiety, depression, dementia or psychosis, gastrointestinal disorders |
| 03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
| 03/27/2001 | US6207197 Microsphere comprising a drug-containing inner core, water insoluble polymeric rate controlling layer, and a bioadhesive outer layer of cationic polymer; treatment of helicobacter pylori |
| 03/27/2001 | US6207188 Omeprazole sodium salt |
| 03/27/2001 | CA2140347C Injection and injection kit containing omeprazole and its analogs |
| 03/27/2001 | CA2065860C Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 03/22/2001 | WO2001020004A2 Protein phosphatase and kinase proteins |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019977A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 03/22/2001 | WO2001019973A2 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019828A2 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | WO2001019826A2 Triazolopyrimidine derivatives |
| 03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | WO2001019824A2 New active marine alkaloids |
| 03/22/2001 | WO2001019823A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 03/22/2001 | WO2001019819A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019817A2 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019802A1 Aromatic nitrogenous six-membered ring compounds |
| 03/22/2001 | WO2001019800A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/22/2001 | WO2001019776A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019401A1 Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019369A1 Use of thienopyrimidines |
| 03/22/2001 | WO2001019367A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 03/22/2001 | WO2001019362A2 Formulations for treating or preventing mucositis |
| 03/22/2001 | WO2001019339A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | WO2001019338A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 03/22/2001 | WO2001019320A2 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | WO2001019161A2 ANTISENSE MODULATION OF TRANSFORMING GROWTH FACTOR-β EXPRESSION |
| 03/22/2001 | WO2001007098A3 A device and method for performing a biological modification of a fluid |
| 03/22/2001 | WO2001000811A3 17867, a novel human aminopeptidase |
| 03/22/2001 | WO2000078341A8 A method for the prophylaxis and/or treatment of medical disorders |
| 03/22/2001 | WO2000069255A8 Anti-inflammatory therapy for inflammatory mediated infection |
| 03/22/2001 | WO2000059899A8 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | WO2000040576A3 Thiopyran compounds as inhibitors of mmp |
| 03/22/2001 | WO2000020591A9 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 03/22/2001 | DE19944604A1 Aminderivate Amine derivatives |
| 03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | CA2387123A1 Use of thienopyrimidines |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2385065A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | CA2385063A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384782A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384656A1 New active marine alkaloids |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2384294A1 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383927A1 Protein phosphatase and kinase proteins |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | CA2381252A1 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/22/2001 | CA2381006A1 Antisense modulation of transforming growth factor-.beta. expression |
| 03/21/2001 | EP1085089A2 Human cyclic nucleotide phosphodiesterase |
| 03/21/2001 | EP1085019A1 Omeprazole synthesis |
| 03/21/2001 | EP1085014A1 1,5-benzodiazepine derivatives |
| 03/21/2001 | EP1084706A2 Use of simethicone to treat ulcerative colitis |
| 03/21/2001 | EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 03/21/2001 | EP1084108A1 Spla 2? inhibitor compounds for treatment of disease |
| 03/21/2001 | EP1084104A1 Nitric oxide synthase inhibitors |
| 03/21/2001 | EP1083916A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083908A1 Use of ozone for the preparation of medicaments for the treatment of dental caries |
| 03/21/2001 | EP1083891A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 03/21/2001 | EP1083887A2 Pharmaceutical compositions for ulcer |
| 03/21/2001 | CN1288468A Antibodies against human IL-12 |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1288370A Mixture contg. honey, at least one essential oil and/or at least one essential oil derivative |
| 03/21/2001 | CN1287858A Traditional Chinese medicinal composition for treating hepatitis and its prepn. method |
| 03/21/2001 | CN1287857A Traditional Chinese patented medicine for treating hepatitis and its prepn. method |
| 03/21/2001 | CN1287838A Health-care products extracted from ostrich blood, penis orchis |